TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05275140

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activity
Description: Combat sports and exercise

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physical activity
Description: Combat sports and exercise

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physical activity
Description: Combat sports and exercise
Study: NCT04399993

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention Protocol in Diaphragm
Description: The protocol consists of three techniques. The two first techniques will be applied for 10 respiratory cycles.~Muscle Stretching Technique:~the researcher will perform a cephalic traction on the inferior costal border with the ulnar border during the inspiratory phase.~Phrenic-center inhibition technique:~the researcher, with a hand on the sternum to caudal and other hand on the umbilical region to cranial, will approach his hands on the horizontal plane, when the volunteer exales.~Functional diaphragm technique:~the researcher will perform a vertical pressure on the diaphragm for 5 minutes and will search for the facilitated parameters and maintain them until the release of all the periarticular elements.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham technique
Description: In the sham group a manual contact without any therapeutic intention will be performed, in a distant region of the diaphragm (for example on the trapezius muscle). This contact will be maintained during the same amount of time as for the treatment group.
Study: NCT06138405

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Immediate intervention Group
Description: The immediate intervention group will be video recorded in office and participate in the training workshop and assessment methods two months after.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Delayed intervention (control) Group
Description: The delayed training group will also be video recorded in office but will wait an additional two months and then participate in the training and assessment methods as with the original training group.
Study: NCT06140797

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Multimodal prehabilitation combined with perioperative ERAS care（PREERAS）
Description: Pre-admission risk assessment and targeted intervention provided by multidisciplinary team
Study: NCT05418153

Intervention type: DEVICE
Intervention: Tecnis Synergy IOL
Description: Intraocular lens replaces the natural lens removed during cataract surgery in both eyes.
Study: NCT05411861

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Analgesic Non Narcotic
Description: Injection of protocol-specified volume of local analgesic

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Analgesic Non Narcotic
Description: Injection of protocol-specified volume of local analgesic

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Analgesic Non Narcotic
Description: Injection of protocol-specified volume of local analgesic
Study: NCT05835544

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator: HIIT Control
Description: Complete 3 sets of five repetitions of 30 seconds cycling at 100% of maximal aerobic power with 30 seconds of active unloaded recovery between repetitions; 3 minutes of passive rest between sets.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental: HIIT + BFR between cycling sets
Description: Complete 3 sets of five repetitions of 30 seconds cycling at 100% of maximal aerobic power with 30 seconds of active unloaded recovery between repetitions; 3 minutes of passive rest between sets. Blood flow restriction is applied for 2 minutes during the passive rest at 80% of limb occlusion pressure.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental: HIIT + BFR moderate occlusion during cycling
Description: Complete 3 sets of five repetitions of 30 seconds cycling at 70% of maximal aerobic power with 30 seconds of active unloaded recovery between repetitions; 3 minutes of passive rest between sets. Blood flow restriction is applied during and between exercise repetitions at 50% of limb occlusion pressure and deflated during passive rest periods.
Study: NCT05372848

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Manual toothbrush
Description: volunteers who used manual toothbrush for at least 2 years

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Electric toothbrush
Description: volunteers who used electric toothbrush for at least 2 years
Study: NCT06445140

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Collecting the variables and Implementation of a behavioural intervention
Description: The observational phase (during 15 days)~* Two measurements per day for motivational variables and physical activity and nutrition~* Two measurements per day for nutrition~* Three measurements per day for fatigue~* Continuous PA measurement by accelerometer~The interventional phase :~Part A (during 7 days)~* measuring physical activity (PA)~* complete questionnaires and numerical scales :~  * Motivational factors~ * Self-evaluation of nutrition~ * Self-assessment of fatigue~Part B: BEHAVIORAL INTERVENTION (10 weeks),the APA teacher will call a patient once a week for follow-up.~Answer questionnaires and scales on the digital platform will be done :~* Motivational factors~* Self-evaluation of nutrition~* Self-assessment of fatigue~Part C : End of interventional phase(during 7 days)~* measuring physical activity~* complete questionnaires and numerical scales :~  * Motivational factors~ * Self-evaluation of nutrition~ * Self-assessment of fatigue
Study: NCT06443970

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Exsalta Suction Device
Description: Low flow endotracheal suction device

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Exsalta Suction Device
Description: Low flow endotracheal suction device
Study: NCT05245708

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Description: Each subject will be assigned to intranasal administration of oxytocin (24 IU).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intranasal placebo
Description: Each subject will be assigned to intranasal placebo.
Study: NCT04918719

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetylcysteine
Description: The dosing of Acetylcysteine will be similar to the standard intravenous acetaminophen toxicity dosing: 150mg/kg in 200 milliliters of 5% Dextrose (D5W) infused over 1 hour, immediately followed by 50mg/kg in 500mL D5W infused over 4 hours, then 100mg/kg in 1000 milliliters D5W infused over 16 hours. (Any patient receiving t-PA who enrolls in the study will have their study drug infusion delayed by 24 hours after the completion of the t-PA infusion. )

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Dextrose in Water
Description: The placebo will consist of a 5% Dextrose in Water instead of NAC (dosage and timigs are the same as the NAC arm). (Any patient receiving t-PA who enrolls in the study will have their study drug infusion delayed by 24 hours after the completion of the t-PA infusion. )
Study: NCT06306937

Intervention type: DIAGNOSTIC_TEST
Intervention: Evalution of serum levels of vitamin D and IL8
Description: Group 1 (Periodontitis Group): The intervention involves observing and analyzing individuals diagnosed with periodontitis based on established clinical criteria. The focus is on assessing vitamin D and IL8 levels in the serum and correlating these levels with the severity of periodontitis, determined by clinical indices such as probing depth, clinical attachment loss, and bleeding on probing.~Group 2 (Control Group): The intervention involves observing and analyzing individuals without any signs or history of periodontal disease. The focus is on assessing vitamin D and IL8 levels in the serum for comparison with the periodontitis group. This group serves as the healthy control for the study.

Intervention type: DIAGNOSTIC_TEST
Intervention: Evalution of serum levels of vitamin D and IL8
Description: Group 1 (Periodontitis Group): The intervention involves observing and analyzing individuals diagnosed with periodontitis based on established clinical criteria. The focus is on assessing vitamin D and IL8 levels in the serum and correlating these levels with the severity of periodontitis, determined by clinical indices such as probing depth, clinical attachment loss, and bleeding on probing.~Group 2 (Control Group): The intervention involves observing and analyzing individuals without any signs or history of periodontal disease. The focus is on assessing vitamin D and IL8 levels in the serum for comparison with the periodontitis group. This group serves as the healthy control for the study.
Study: NCT05888740

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VibratoSleeve Therapeutic Ultrasound Device
Description: The VibratoSleeve is compromised of a 16-transducer array that is mounted within a wrap that conforms to the posterior calf
Study: NCT04967118

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact
Description: Diaper clad baby will be placed ventral position on bare chest of mother 30 minute prior to the heel lance

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mother's heartbeats as sound and vibration
Description: The mother's heartbeat will be recorded and the heartbeat sounds will be saved to the platform. The platform will be placed under the infant's mattress and the heartbeat will be started 30 minute prior to the heel lance.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 30% oral glucose
Description: The infant will be given 30% oral glucose solution 2 minutes before the injection
Study: NCT05773235

Intervention type: DIAGNOSTIC_TEST
Intervention: Combined 3- and 7 Tesla-MRI
Description: 7 Tesla-MRI including the following sequences: susceptibility weighted imaging (SWI), T1, T2, FLAIR, quantitative mapping sequences (T1mapping, qSM)

Intervention type: DIAGNOSTIC_TEST
Intervention: Combined 3- and 7 Tesla-MRI
Description: 7 Tesla-MRI including the following sequences: susceptibility weighted imaging (SWI), T1, T2, FLAIR, quantitative mapping sequences (T1mapping, qSM)
Study: NCT05766202

Intervention type: OTHER
Group type: OTHER
Intervention: An group intervention for multiparas with fear of childbirth
Description: The intervention consists of 4 group meetings, three during pregnancy and once after giving birth. It also includes a phone call.
Study: NCT05835544

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental: HIIT + BFR high occlusion during cycling
Description: Complete 3 sets of five repetitions of 30 seconds cycling at 70% of maximal aerobic power with 30 seconds of active unloaded recovery between repetitions; 3 minutes of passive rest between sets. Blood flow restriction is applied during and between exercise repetitions at 80% of limb occlusion pressure and deflated during passive rest periods.
Study: NCT05168189

Intervention type: DRUG
Intervention: Ivabradine
Description: follow up chronic coronary syndrome patients receiving Ivabradine for ( 6 months ) if the participants develop atrial fibrillation using 24 hours holter .

Intervention type: DIAGNOSTIC_TEST
Intervention: transthoracic echo
Description: performing baseline transthoracic echo for all patients to exclude any chamber dilatation

Intervention type: DIAGNOSTIC_TEST
Intervention: transthoracic echo
Description: performing baseline transthoracic echo for all patients to exclude any chamber dilatation

Intervention type: DEVICE
Intervention: 24 hours holter
Description: perform 24 hours Holter monitoring for all patients at the start of the study and follow up after 6 months

Intervention type: DEVICE
Intervention: 24 hours holter
Description: perform 24 hours Holter monitoring for all patients at the start of the study and follow up after 6 months
Study: NCT04851522

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Di-Dak-Sol
Description: Topical solution applied externally.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: White Petrolatum
Description: Topical ointment applied externally
Study: NCT05439629

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BAT5906 injection
Description: 4.0 mg/eye/time, 50 μl, intravitreal injection

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lucentis
Description: 0.5 mg/eye/time, 50 μl, intravitreal injection
Study: NCT05246826

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Pilates Exercises
Description: Pilates exercises; warm-up and cool-down exercises will be performed for 5 repetitions, while other exercises will be performed by the same physiotherapist as 10 repetitions depending on the patient's pain and fatigue. The exercises will be advanced at the end of the 3rd week.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Pilates Exercises and Conventional Treatment
Description: In addition to pilates exercises, a conventional treatment program will be applied. As part of the conventional treatment program, 20 minutes of Hotpack to the cervical area, 20 minutes of conventional Transcutaneous Electrical Nerve Stimulation (TENS) to the painful area (80 Hertz (Hz), 100 microseconds (μs), until tingling is felt, asymmetrical biphasic rectangular waveform), 8 minutes to the cervical area Ultrasound (US) (4 minutes + 4 minutes, 1.5 watts/cm2, 1 MHz, continuous) will be applied.
Study: NCT05789186

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CAVO aromatherapy patch at 3% concentration+Fluoxetine hydrochloride mimetic
Description: CAVO aromatherapy patch at 3% concentration enhances neuroelectrical activity in the brain (especially in the prefrontal cortex), exerting an antidepressant effect.Fluoxetine hydrochloride mimetic without drug treatment effect.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluoxetine hydrochloride tablet+CAVO aromatherapy patch at 0.1% concentration
Description: Fluoxetine hydrochloride tablet was widely used selective 5-HT reuptake inhibitor (SSRI) that selectively inhibits the 5-HT transporter, blocks the reuptake of 5-HT by the presynaptic membrane, and prolongs and increases the effects of 5-HT, resulting in antidepressant effects.CAVO aromatherapy patch at 0.1% concentration without drug treatment effect.

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Fluoxetine hydrochloride mimetic+CAVO aromatherapy patch at 0.1% concentration
Description: Placebo without drug treatment effect
Study: NCT05593276

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Empower@Home
Description: Participants will be provided with access to a 9-session online program and will receive supportive remote assistance throughout regarding technical and programmatic issues.
Study: NCT05389501

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social policy intervention to support women of reproductive years
Description: The project team will attempt to address this challenge by delivering the following interventions through social workers in underdeveloped primary healthcare settings to promote maternal and child health:~1. Developing a database on a digital app of participants in the study and use the data for development of an Index for Maternal Health and Wellbeing~2. Conducting a Community Assessment Needs~3. Conduct a psychosocial needs assessment~4. Develop interprofessional health workforce collaboration~5. Measure basic clinical health indicators~6. Provide health awareness and literacy training to participants

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social policy intervention to support women of reproductive years
Description: The project team will attempt to address this challenge by delivering the following interventions through social workers in underdeveloped primary healthcare settings to promote maternal and child health:~1. Developing a database on a digital app of participants in the study and use the data for development of an Index for Maternal Health and Wellbeing~2. Conducting a Community Assessment Needs~3. Conduct a psychosocial needs assessment~4. Develop interprofessional health workforce collaboration~5. Measure basic clinical health indicators~6. Provide health awareness and literacy training to participants
Study: NCT04809623

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Edecesertib
Description: Tablets administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo to match edecesertib tablets administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standard of Care
Description: Immunosuppressive/immunomodulatory agents including but not limited to antimalarials (i.e. hydroxychloroquine), methotrexate, azathioprine and corticosteroids (i.e. prednisone)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standard of Care
Description: Immunosuppressive/immunomodulatory agents including but not limited to antimalarials (i.e. hydroxychloroquine), methotrexate, azathioprine and corticosteroids (i.e. prednisone)
Study: NCT06365892

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: open-label placebo
Description: Placebo will be supplied as a 330mg tablet (manufactured by Consolidated Midland Corporation). Patients will take placebo with each oral opioid intake and 3 additional times per day beginning on POD 1.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment as usual
Description: Each oral opioid dose is a 5mg Oxycodone tablet. Investigator shall never prescribe ibuprofen. Investigator shall always prescribe Tylenol 625mg every 8hrs (PRN).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment as usual
Description: Each oral opioid dose is a 5mg Oxycodone tablet. Investigator shall never prescribe ibuprofen. Investigator shall always prescribe Tylenol 625mg every 8hrs (PRN).
Study: NCT06360510

Intervention type: PROCEDURE
Intervention: %5 dextrose injection
Description: hydrodissection with %5 dextrose

Intervention type: PROCEDURE
Intervention: betamethasone injection
Description: perineural betamethasone injection
Study: NCT06112847

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study: NCT04771650

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CAMI
Description: The CAMI is a culturally adapted motivational interview. It is a single 75 minute session that focuses on promoting motivation to change drinking and drug use behavior.
Study: NCT06112847

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT or PET/CT

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic Health Record Review
Description: Ancillary studies

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Epcoritamab
Description: Given SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Given PO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study: NCT04919135

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Umbilical Cord Mesenchymal Stem Cells transplantation
Description: Patients assigned to UC-MSC administration groups will receive two administrations at a dose of 1.5 million cells/kg patient body weight via the IV route with a 3-month intervening interval

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: standard frailty treatment and supplementary medication
Description: Hightamine (Hankook Korus Pharm, Korea), Total calcium (Nugale Pharmaceutical, Canada), Bioflex (Ausbiomed, Australia)

Intervention type: DRUG
Group type: OTHER
Intervention: standard frailty treatment and supplementary medication
Description: Hightamine (Hankook Korus Pharm, Korea), Total calcium (Nugale Pharmaceutical, Canada), Bioflex (Ausbiomed, Australia)
Study: NCT06435455

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GH21
Description: GH21 Capsules, Oral Drug Specification: 3mg/capsule; 10mg/capsule

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D-1553
Description: D-1553 Film-coated Tablets, Oral Drug Sepcification: 200mg/tablet
Study: NCT06112847

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT
Study: NCT05903885

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: On-site Fecal Immunochemical Test (FIT) Kit Distribution
Description: Participants will receive home based Fecal Immunochemical Test (FIT) kit directly at the DMV site by the research staff.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Onsite with social media advertising Fecal Immunochemical Test (FIT) Kit Distribution
Description: Participants will receive home-based Fecal Immunochemical Test (FIT) kits directly at the DMV location through face-to-face contact, supplemented by exposure to targeted social media advertisements.
Study: NCT05275946

Intervention type: DRUG
Group type: OTHER
Intervention: Targeted alpha therapy
Description: Single intravenous administration
Study: NCT06260137

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Rhomboid intercostal block
Description: Patients will be injected with a local anesthetic drug under the rhomboid intercostal muscle before surgery.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Rhomboid intercostal and subserratus plane block
Description: Patients will be injected with a local anesthetic drug under the rhomboid intercostal muscle and the serrates anterior muscle before surgery.
Study: NCT06254664

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 µg inhalation powder, hard capsule
Description: Tiotropium 18 µg administered using Zephir inhaler

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Zephir inhaler
Description: Tiotropium 18 µg administered using Zephir inhaler
Study: NCT04451369

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prehabilitation program
Description: physical, nutritional and psycho-social supports before surgery
Study: NCT05780164

Intervention type: OTHER
Intervention: Research readiness tool
Description: Online/paper based tool containing information about lung cancer clinical trials
Study: NCT06521437

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TMS targeting the hippocampus indirectly via its network
Description: Subjects will receive high-frequency repetitive TMS to a parieto-occipital location defined in each subject based on high resting-state fMRI connectivity with the hippocampus at baseline
Study: NCT05970094

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low PRAL
Description: Two weeks on a low PRAL diet compared to 2 week free living
Study: NCT05493189

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Additional autonomous training sessions
Description: The duration of the autonomous training will be 30 minutes, using a feedback CPR training simulator (eg Laerdal Little Anne QCPR).